Bliss GVS Pharma share news, announcements and annual reports
NSE: BLISSGVSBSE: 506197Pharmaceuticals & BiotechnologySmall Cap
Bliss GVS Pharma Limited · Face value ₹1 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Oct 1985 on BSE, Jul 2010 on NSE
Last close ₹647.50down ₹33.40 (4.91%)BSE ₹648.40
Share price at the NSE close on 30 Oct 2026. Previous close ₹680.90.
30 Oct: open ₹660.00, high ₹670.00, low ₹646.90
52-week range of traded prices to 30 Oct 2026
₹118.00Low, 10 Nov 2025₹739.90High, 28 Sep 2026
- Under NSE's long-term additional surveillance, stage IV, on the list for 30 Oct 2026. The exchange puts a share here when its price has moved unusually, and trading in it carries extra conditions.
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹6,885 Cr1,000th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 42.71
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 5.34
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- 0.23%
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 13.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- 14.9%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Sep 2026.
- 0.00
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 4,45,760
Bliss GVS Pharma share news and announcements
628 announcements, routine notices left out, newest first. Page 11 of 13.
Apr 2016
Feb 2016
Nov 2015
9 Nov · Board meeting
Oct 2015
Sep 2015
Aug 2015
Jul 2015
2 Jul · Updates
May 2015
30 May · Legal
Exchange has sought clarification from Bliss GVS Pharma Limited with respect to announcement vide letter dated May 29, 2015 wherein "the Board has considered and approved Sale of Step Down subsidiary "Surgimed Pharma Limited" located at Kenya". On basis of above Company is required to clarify : 1. The amount and percentage of the turnover or revenue or income and net worth contributed by such entity during the last financial year. 2. The Expected date of Completion. 3. Rational. The reply from the Company is awaited.30 May · Code of Conduct under SEBI(PIT) Reg., 2015
30 May · Board meeting
Mar 2015
Feb 2015
12 Feb · Corporate action
Company has fixed Record Date as February 25, 2015 for the purpose of interim dividend.12 Feb · Dividend
Board of directors of the Company at its meeting held on February 12, 2015, has considered and approved interim dividend @ 20% ie Re. 0.20 per share of face value of Re. 1 each.
Oct 2014
31 Oct · Board meeting
Board of Directors of the Company at its meeting held on October 30, 2014, has considered and approved the followings: (1) Enlargement of the object of the Company by inclusion of commodities Trading. (2) Consider, negotiate & finalize purchase of substantial stake in Shree Sales Pack Pvt Ltd ,who presently carries majorities of packaging business for the Company. (3) Consider the proposal of opening office of the Company at London either by setting a subsidiary or representative office.16 Oct · Board meeting
Inter-alia to consider the Unaudited Financial Results of the Company for the quarter ended September 30, 2014.
Aug 2014
28 Aug · Meeting
Annual General Meeting of the Company held on August 28, 2014 the following resolutions were passed with absolute majority: 1) Adoption of Financial Statements for the year ended March 31, 2014. 2) Reappointment of Mr. S.R. Vaidya as an Independent Director for 5 consecutive years. 3) Reappointment of M/s B .K Khare & Co. as an Auditor for 3 consecutive years. 4) Declaration of Dividend @50% (i.e. Rs. 0.50/-per share) 5) to approve the remuneration payable to cost auditors, M/s Y.R. Doshi & Associates for the financial Year 2014-15. 6) Renting of Office Premises from Promoters. 7) Loans and Guarantees to Subsidiaries. 8) Power to Borrow Money.
Jul 2014
31 Jul · Meeting
Register of Members & Share Transfer Books of the Company will remain closed from August 18, 2014 to August 22, 2014 (both days inclusive) for the purpose of declaration of Dividend. Further, the Annual General Meeting of the Company is scheduled to be held on August 28, 2014.30 Jul · Board meeting
To consider interalia, the Un-audited Financial Results of the Company for the Quarter ended June 30, 2014.
Jun 2014
2 Jun · Dividend
Board of Directors of the Company at its meeting held on May 26, 2014, has recommended a Final Dividend of 50% i.e. Rs. 0.50/- per Equity Share for the year ended March 31, 2014
May 2014
16 May · Board meeting
To consider interalia:- (1) The Audited Financial Results of the company for the quarter and year ended March 31, 2014; (2) And dividend, if any.
Mar 2014
19 Mar · Management
Mrs. Sushma Yadav is appointed as a Company Secretary of the Company on account of resignation of Mr. Amarendra Mohapatra.
Feb 2014
12 Feb · Results
4 Feb · Board meeting
To Consider interalia, the un-audited Financial Results of the Company for the Quarter ended December 31, 2013.
Nov 2013
15 Nov · Results
6 Nov · Board meeting
To consider interalia, the Un-audited Financial Results of the Company for the Quarter ended September 30, 2013.
Oct 2013
3 Oct · Updates
Company has come to know from shareholders and from social media sites that Pfizer is taking with the management to acquire stake in the Company. The Company has deny this news and the Company is not in any discussion with M/s Pfizer Ltd or its management or not given any mandate for discussion of sale of any of its units or stake of the Company. This news is purely based on rumours.